Ther Innov Regul Sci

Investigation of Approval Trends and Benefits of New Fixed-Dose Combination Drugs in Japan.

Kikuchi C, Ohno M, Izumo T, Takahashi S, Aoki M, Shimomura H, Kawano Y, Shimada S, Aoyama T

New fixed-dose combination drugs (FDCs) had been developed in limited numbers in Japan. Since regulatory requirements were relaxed in 2005, 73 new FDC ... Read More

Source: PubMed

Am. J. Ophthalmol. 2020 Jan 29

Baseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): A multicentre randomised controlled trial.

King AJ, Hudson J, Fernie G, Burr J, Azuara-Blanco A, Sparrow J, Barton K, Garway-Heath DF, Kernohan A, MaClennan G

To report the baseline characteristics of participants enrolled in the Treatment of Advanced Glaucoma Study (TAGS) DESIGN: Pragmatic randomised contro ... Read More

Source: PubMed

Ophthalmology 2019 Oct 30

Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial.

Garg A, Vickerstaff V, Nathwani N, Garway-Heath D, Konstantakopoulou E, Ambler G, Bunce C, Wormald R, Barton K, Gazzard G

To determine the efficacy of repeat selective laser trabeculoplasty (SLT) in medication-naive open-angle glaucoma (OAG) and ocular hypertensive (OHT) ... Read More

Source: PubMed

Am. J. Ophthalmol. 2020 Jan 28

Predictors of Neovascular Glaucoma in Central Retinal Vein Occlusion.

Gandhi JS

Read More

Source: PubMed

Ann Palliat Med

Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy.

Chen HJ, Wang CG, Dou HL, Feng XF, Xu YM, Ma ZZ

Younger patients who underwent vitrectomy for proliferative diabetic retinopathy (PDR) display more aggressive nature distinguished from the older pat ... Read More

Source: PubMed